🇺🇸 therapeutic testosterone in United States

FDA authorised therapeutic testosterone on 12 October 1993

Marketing authorisation

FDA — authorised 12 October 1993

  • Application: NDA019762
  • Marketing authorisation holder: ALZA
  • Local brand name: TESTODERM
  • Indication: FILM, EXTENDED RELEASE — TRANSDERMAL
  • Status: approved

Read official source →

therapeutic testosterone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Endocrinology / Oncology approved in United States

Frequently asked questions

Is therapeutic testosterone approved in United States?

Yes. FDA authorised it on 12 October 1993.

Who is the marketing authorisation holder for therapeutic testosterone in United States?

ALZA holds the US marketing authorisation.